Notice2024-20500

National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meetings

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
September 11, 2024

Issuing agencies

Health and Human Services DepartmentNational Institutes of Health

Full Text

<html>
<head>
<title>Federal Register, Volume 89 Issue 176 (Wednesday, September 11, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 176 (Wednesday, September 11, 2024)]
[Notices]
[Page 73665]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-20500]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Arthritis and Musculoskeletal and Skin 
Diseases; Notice of Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Arthritis and Musculoskeletal and Skin 
Diseases Initial Review Group: Arthritis and Musculoskeletal and 
Skin Diseases Special Grants Study Section.
    Date: October 17-18, 2024.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, One Democracy Plaza, 6701 
Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Yasuko Furumoto, Ph.D., Scientific Review 
Officer, Scientific Review Officer; Scientific Review Branch, 
Extramural Program, Arthritis and Musculoskeletal and Skin Diseases, 
6701 Democracy Boulevard, Room 820, Bethesda, MD 30892, 301-827-
7835, <a href="/cdn-cgi/l/email-protection#a5dcc4d6d0ceca8bc3d0d7d0c8cad1cae5cbcccd8bc2cad3"><span class="__cf_email__" data-cfemail="50293123253b3f7e362522253d3f243f103e39387e373f26">[email&#160;protected]</span></a>.

    Name of Committee: Arthritis and Musculoskeletal and Skin 
Diseases Initial Review Group: Arthritis and Musculoskeletal and 
Skin Diseases Clinical Trials Study Section.
    Date: October 24-25, 2024.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, One Democracy Plaza, 6701 
Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Sushmita Purkayastha, Ph.D., Scientific Review 
Officer, Scientific Review Branch, Extramural Program, Arthritis and 
Musculoskeletal and Skin Diseases, 6701 Democracy Boulevard, Room 
814, Bethesda, MD 20817, 301-201-7600, <a href="/cdn-cgi/l/email-protection#136066607b7e7a67723d63666178726a7260677b72537d7a7b3d747c65"><span class="__cf_email__" data-cfemail="5b282e283336322f3a752b2e29303a223a282f333a1b353233753c342d">[email&#160;protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.846, 
Arthritis, Musculoskeletal and Skin Diseases Research, National 
Institutes of Health, HHS)

    Dated: September 5, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-20500 Filed 9-10-24; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on September 11, 2024.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.